R.P. Mueller

2.7k total citations
24 papers, 927 citations indexed

About

R.P. Mueller is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, R.P. Mueller has authored 24 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 13 papers in Pathology and Forensic Medicine and 9 papers in Surgery. Recurrent topics in R.P. Mueller's work include Lung Cancer Treatments and Mutations (13 papers), Lymphoma Diagnosis and Treatment (12 papers) and Esophageal Cancer Research and Treatment (8 papers). R.P. Mueller is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lymphoma Diagnosis and Treatment (12 papers) and Esophageal Cancer Research and Treatment (8 papers). R.P. Mueller collaborates with scholars based in Germany, Switzerland and Austria. R.P. Mueller's co-authors include Stephan Baldus, Paul M. Schneider, Elfriede Bollschweiler, Hans Peter Dienes, Ralf Metzger, Arnulf H. Hoelscher, Hartmut Schaefer, J. Thiele, Rudolf Bongartz and Martin Köcher and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Surgery.

In The Last Decade

R.P. Mueller

23 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.P. Mueller Germany 10 596 550 337 238 91 24 927
Jennifer A. Dorth United States 15 248 0.4× 272 0.5× 371 1.1× 115 0.5× 76 0.8× 60 837
Su Jung Shim South Korea 14 303 0.5× 156 0.3× 294 0.9× 247 1.0× 57 0.6× 34 819
Gamal El-Husseiny Saudi Arabia 12 246 0.4× 229 0.4× 266 0.8× 69 0.3× 58 0.6× 26 678
Keith Unger United States 17 275 0.5× 373 0.7× 398 1.2× 52 0.2× 45 0.5× 64 940
Yong-Wen Song China 13 248 0.4× 132 0.2× 588 1.7× 612 2.6× 117 1.3× 54 870
Renyan Gong China 7 586 1.0× 475 0.9× 425 1.3× 63 0.3× 20 0.2× 9 961
Ryunosuke Machida Japan 10 302 0.5× 291 0.5× 226 0.7× 47 0.2× 125 1.4× 61 659
Yu-Hong Li China 15 285 0.5× 392 0.7× 606 1.8× 101 0.4× 13 0.1× 19 922
Esra Kaytan Türkiye 10 174 0.3× 189 0.3× 240 0.7× 115 0.5× 34 0.4× 18 480
Tanja Pelz Germany 10 92 0.2× 152 0.3× 157 0.5× 167 0.7× 68 0.7× 16 562

Countries citing papers authored by R.P. Mueller

Since Specialization
Citations

This map shows the geographic impact of R.P. Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.P. Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.P. Mueller more than expected).

Fields of papers citing papers by R.P. Mueller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.P. Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.P. Mueller. The network helps show where R.P. Mueller may publish in the future.

Co-authorship network of co-authors of R.P. Mueller

This figure shows the co-authorship network connecting the top 25 collaborators of R.P. Mueller. A scholar is included among the top collaborators of R.P. Mueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.P. Mueller. R.P. Mueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haverkamp, Uwe, Rudolf Bongartz, Christian Baues, et al.. (2012). Quality control of involved-field radiotherapy for patients with early stage Hodgkin’s lymphoma based on a central prospective review. Strahlentherapie und Onkologie. 188(8). 660–665. 4 indexed citations
2.
Abo‐Madyan, Yasser, Hans Theodor Eich, Florian Stieler, et al.. (2012). Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin’s disease. Strahlentherapie und Onkologie. 188(8). 653–659. 4 indexed citations
3.
Tresckow, Bastian von, Annette Plütschow, Michael Fuchs, et al.. (2012). Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial. Journal of Clinical Oncology. 30(9). 907–913. 173 indexed citations
4.
Eich, Hans Theodor, R.P. Mueller, Volker Diehl, et al.. (2010). Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavorable Hodgkin Lymphoma: Final Analysis of the German Hodgkin Study Group (GHSG) Randomized HD11 Trial. International Journal of Radiation Oncology*Biology*Physics. 78(3). S1–S1. 2 indexed citations
5.
6.
7.
8.
Warnecke‐Eberz, Ute, Ralf Metzger, Elfriede Bollschweiler, et al.. (2009). TaqMan ® Low-Density Arrays and Analysis by Artificial Neuronal Networks Predict Response to Neoadjuvant Chemoradiation in Esophageal Cancer. Pharmacogenomics. 11(1). 55–64. 23 indexed citations
9.
Klußmann, Jens Peter, et al.. (2008). Patterns of lymph node spread and its influence on outcome in resectable parotid cancer. European Journal of Surgical Oncology. 34(8). 932–937. 101 indexed citations
10.
11.
Eich, Hans Theodor, et al.. (2008). Response-adapted Therapy using FDG-PET after BEACOPP-chemotherapy in Advanced Stage Hodgkin's Lymphoma - An Interim Analysis of the German Hodgkin Study Group (GHSG) Trial HD15. International Journal of Radiation Oncology*Biology*Physics. 72(1). S471–S471. 1 indexed citations
12.
Ling, Frederike C., Stephan Baldus, Susanne Neiß, et al.. (2007). HIF-1alpha mRNA is not associated with histopathological regression following neoadjuvant chemoradiation in esophageal cancer.. PubMed. 26(6B). 4505–9. 9 indexed citations
13.
Prenzel, Klaus, Alexandra König, Paul M. Schneider, et al.. (2006). Reduced Incidence of Nodal Micrometastasis after Major Response to Neoadjuvant Chemoradiation in Locally Advanced Esophageal Cancer. Annals of Surgical Oncology. 14(2). 954–959. 30 indexed citations
14.
Schneider, Paul M., Stephan Baldus, Ralf Metzger, et al.. (2005). Histomorphologic Tumor Regression and Lymph Node Metastases Determine Prognosis Following Neoadjuvant Radiochemotherapy for Esophageal Cancer. Annals of Surgery. 242(5). 684–692. 303 indexed citations
15.
Warnecke‐Eberz, Ute, Shuichi Hokita, Hiroshi Higashi, et al.. (2005). Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer. Oncology Reports. 13(6). 1241–6. 34 indexed citations
16.
Eich, Hans‐Theodor, Uwe Haverkamp, Andreas Engert, et al.. (2004). Biophysical analysis of acute toxicity of radiotherapy in Hodgkin’s lymphoma — a comparison between extended field and involved field radiotherapy based on the data of the german hodgkin study group (GHSG). International Journal of Radiation Oncology*Biology*Physics. 60(1). S219–S219.
17.
Miyazono, Futoshi, Ralf Metzger, Ute Warnecke‐Eberz, et al.. (2004). Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. British Journal of Cancer. 91(4). 666–672. 39 indexed citations
18.
Diehl, Volker, Corinne Brillant, Andreas Engert, et al.. (2004). Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.. Blood. 104(11). 1307–1307. 9 indexed citations
19.
Warnecke‐Eberz, Ute, Ralf Metzger, Stephan Baldus, et al.. (2004). High Specificity of Quantitative Excision Repair Cross-Complementing 1 Messenger RNA Expression for Prediction of Minor Histopathological Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer. Clinical Cancer Research. 10(11). 3794–3799. 91 indexed citations
20.
Eckel, H. E., Volker Rudat, Andreas Dietz, et al.. (2001). Benefits and toxicities of accelerated radiochemo- versus accelerated radiotherapy in advanced head and neck cancer - results of a German randomized study. European Journal of Cancer. 37. S38–S38. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer A. Dorth Breakdown of academic impact, for papers by Su Jung Shim Breakdown of academic impact, for papers by Gamal El-Husseiny Breakdown of academic impact, for papers by Keith Unger Breakdown of academic impact, for papers by Yong-Wen Song Breakdown of academic impact, for papers by Renyan Gong Breakdown of academic impact, for papers by Ryunosuke Machida Breakdown of academic impact, for papers by Yu-Hong Li Breakdown of academic impact, for papers by Esra Kaytan Breakdown of academic impact, for papers by Tanja Pelz
Rankless by CCL
2026